eli lilly tirzepatide patent expiry 🚨 Generic Versions of Mounjaro & Zepbound Move Closer as FDA Reviews First Applications The US Food and Drug Administration (FDA) is reviewing the first applications for generic versions of Lilly's Patent expiry looms: Eli Lilly

The EMA review process takes approximately 12 to 15 months, longer than the FDA

Plaintiffs argue that the manufacturer, Novo Nordisk, failed to adequately warn patients and healthcare providers about these risks

If side effects are severe or persistent beyond the first few weeks, your GP or diabetes specialist may suggest: Temporary dose reduction Anti-emetic medication for nausea Review of concomitant diabetes medications to reduce hypoglycaemia risk Alternative GLP-1 receptor agonist formulations if oral semaglutide remains poorly tolerated According to NICE guidelines (NG28) , treatment decisions should be individualised based on efficacy, tolerability, patient preference, and cost-effectiveness

Patel guides patients through these techniques during consultations, offering practical tips to enhance comfort and effectiveness of the semaglutide injections

Guidelines may change quickly, and selections might expand or contract over time